(Q44805645)

English

Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy

scientific article published in April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 December 2017

Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy (English)

1 reference

Europe PubMed Central

6 December 2017

circulatory system

1 reference

based on heuristic

inferred from title

Peter Stenvinkel

1

1 reference

Europe PubMed Central

6 December 2017

2

1 reference

Europe PubMed Central

6 December 2017

3

object named as

Bengt Lindholm

1 reference

Europe PubMed Central

6 December 2017

Olof Heimbürger

4

object named as

Olof Heimbürger

1 reference

Europe PubMed Central

6 December 2017

language of work or name

0 references

publication date

1 April 2004

1 reference

Europe PubMed Central

6 December 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

6 December 2017

19

1 reference

Europe PubMed Central

6 December 2017

4

1 reference

Europe PubMed Central

6 December 2017

972-976

1 reference

Europe PubMed Central

6 December 2017

Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH035

21 January 2018

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH035

21 January 2018

Oxidative stress in end-stage renal disease: an emerging threat to patient outcome

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH035

21 January 2018

Plasmenylethanolamine is the major storage depot for arachidonic acid in rabbit vascular smooth muscle and is rapidly hydrolyzed after angiotensin II stimulation

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH035

21 January 2018

A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH035

21 January 2018

Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome).

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH035

21 January 2018

Association between myeloperoxidase levels and risk of coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH035

21 January 2018

Myeloperoxidase-derived reactive chlorinating species from human monocytes target plasmalogens in low density lipoprotein

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH035

21 January 2018

Plasma oxidative parameters and mortality in patients with severe burn injury

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH035

21 January 2018

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH035

21 January 2018

Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH035

21 January 2018

Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH035

21 January 2018

Diabetes, oxidative stress, and antioxidants: a review

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH035

21 January 2018

Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH035

21 January 2018

The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH035

21 January 2018

Identifiers

10.1093/NDT/GFH035

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44805645&oldid=2043467614"